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Interferencesvirus 1 (EHV-1) preparations enriched for defective interfering particles (DIP)
leads to a state of persistent infection in which infected cells become lysis resistant and release both
infectious (standard) virus and DIP. EHV-1 DIP are unique in that the recombination events that generate DIP
genomes produce new open reading frames (ORFs; Hyb1.0 and Hyb2.0) consisting of 5′ sequences of varying
lengths of the early regulatory gene IR4 fused to 3′ sequences of varying lengths of the UL5 regulatory gene.
Only two additional ORFs (UL3 and UL4) are conserved. Because persistently infected cells release a
heterogeneous mixture of DIP, characterization of the elements responsible for this altered state of infection
has proved difﬁcult. Here we describe a method for studying persistent infection using recombinant DIP
(rDIP). Infection with rDIP resulted in the production of recombinant DIP that replicated faithfully to, at least,
ﬁve passages and mediated a rapid progression to persistent infection as measured by: 1) production of cells
resistant to lysis by the standard virus; and 2) infected cells that released both standard virus and DIP. High
concentrations of rDIP also resulted in interference with the standard virus replication, another hallmark of
persistent infection. rDIP deleted of UL3, UL4, and either Hyb gene, the only functional genes conserved in
the DIP genome, replicated but exhibited markedly reduced ability to interfere with standard virus
replication. Restoring only the Hyb genes (either Hyb1.0 or Hyb2.0), the IR4 gene, or speciﬁc portions of the
IR4 gene restored interference. These data suggest that residues 144 to 196 of the IR4 protein within the HYB
proteins are important for DIP interference and that persistent infection results from recombination events
that produce DIP genomes.
© 2008 Elsevier Inc. All rights reserved.Introduction
Aswithmany viruses, highmultiplicity infectionswith EHV-1 lead to
the production of defective interfering particles (DIP; Huang and
Baltimore, 1970; Campbell et al., 1976; Barrett and Dimmock, 1986;
Deng et al., 2004; Ebner and O'Callaghan, 2006; O'Callaghan and
Osterrieder, 2008). EHV-1 DIP result from recombination events that
reduce the 155 kbp EHV-1 genome to much smaller 6.0 to 7.5 kbp DIP
genomes that contain only three open reading frames (ORFs): UL3, UL4,
and one of two unique hybrid ORFs (Hyb1.0 or Hyb2.0) which consist of
portions of IR4, a homologue of herpes simplex virus-1 (HSV-1) ICP22,
fused to portions of UL5, a homologue of HSV-1 ICP27. The origin of
replication (ORIs) and cleavage/packaging sequences (CPS) are retained
for replication and packaging (Baumann et al., 1984, 1986, 1987, 1989;
Yalamanchili and O'Callaghan, 1990a,b, 1991; Yalamanchili et al., 1990;y and Immunology, Louisiana
ghway, Shreveport, LA 71130-
ocall@lsuhsc.edu
915 W. State Street, Purdue
l rights reserved.Chen et al., 1996, 1999; Ebner and O'Callaghan, 2006). Comparisons
between the standard virus genome and the DIP genomes are described
schematically in Fig. 1.
High concentrations of DIP lead to a state of persistent infection in
which infected cells become lysis resistant but release both standard
virus and DIP (Henry et al., 1979, 1980; Robinson et al., 1980;
Dauenhauer et al., 1982). One focus of our laboratory has been the
characterization of DIP elements responsible for this altered state of
infection with an emphasis on the roles of the HYB proteins, the
functions of which remain unclear. During lytic infection, both the IR4
protein (IR4P) and the UL5 protein (UL5P) are early auxiliary
regulatory proteins that enhance immediate early protein (IEP)-
mediated trans-activation of EHV-1 promoters (Holden et al., 1992,
1994, 1995; Zhao et al., 1995; Kim et al., 1997; Derbigny et al., 2000,
2002; Albrecht et al., 2004, 2005). In vitro reporter (chloramphenicol
acetyl transferase) assays, however, showed that the HYB1.0 protein
may have a negative effect on gene expression by independently
down-regulating trans-activation of IE and IR4 promoters and
reducing the ability of IR4P or UL5P to act synergistically with the
IEP to up-regulate early EHV-1 promoters (Chen et al., 1996, 1999).
Persistently infected cells release a heterogenous mixture of DIP
which has confounded efforts to identify DIP elements responsible for
Fig. 1. Organization of standard and defective EHV-1 genomes. (A) The standard EHV-1 genome is a two-isomer molecule of approximately 155 kbp and is comprised of 78 known
genes (Henry et al., 1981; Telford et al., 1991). (B) DIP genomes contain only UL3, UL4, a CPS, ORI, and one of two unique genes (Hyb1.0 and Hyb2.0) that form as a result of the
recombination event that generates the defective genome. The Hyb genes contain sequences of IR4 fused to sequences of UL5. The dramatically truncated defective genomes (∼6–
7.5 kbp) are repeated as a concatamer to produce packaged DNA approximately the size of the standard virus genome. Differences in DIP genome molecular weight are due to
differences in the amounts of 3′ non-coding, repeat DNA sequences retained from the parent virus (Ebner and O'Callaghan, 2006). (C) HYB1.0 contains the amino 196aa of IR4P (from a
total of 293aa) fused to the carboxy 68aa of UL5P (from a total of 470aa); HYB2.0 consists of the amino 228aa of IR4P fused to 15 aa⁎ that are generated from a frameshifted reading of
UL5 sequences. (D) Organization of recombinant DIP plasmids. DIP genomes were inserted into pSV-β-galactosidase which contains a functional lacZ operon; DIP2 and DIP3 contain
the Hyb1.0 gene while DIP1 contains the Hyb2.0 gene; ⁎⁎⁎DIP1, DIP2, and DIP3 each contain areas of non-coding sequences of different lengths (Ebner and O'Callaghan, 2006). See
Table 3 for complete descriptions of each plasmid used in this study.
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Dauenhauer et al., 1982; Ebner and O'Callaghan, 2006). Here we
describe a method of studying persistent infection that circumvents
this and other obstacles to studying persistent infection by using
recombinant DIP (rDIP). rDIP replicated faithfully and mimicked wild-
type DIP in their ability to both produce lysis resistant cells and inhibit
standard virus replication, which are two hallmarks of EHV-1
persistent infection. Mutant rDIP deleted of all functional genes
(UL3, UL4, and either Hyb1.0 or Hyb2.0) replicated but did not interfere
signiﬁcantly with standard virus replication. Restoring sequences that
encode either the IR4/UL5 hybrid protein or speciﬁc portions of the
IR4 protein restored interference. Models describing persistentinfection development and potential functions of HYB proteins during
persistent infection are discussed.
Results
rDIP replicate in EHV-1-infected cells
Three distinct DIP genomes (DIP1, DIP2, and DIP3)were cloned into
the expression plasmid pSV-β-galactosidase (Fig. 1). Mouse LM cells
were transfected with the different rDIP constructs (rDIP1, rDIP2,
rDIP3), subsequently infectedwith standard virus (MOI=0.1) to supply
trans-acting factors and structural proteins, and passaged every 72 h
Fig. 2. Generation of recombinant defective interfering particles. LM cells were transfected with plasmids containing DIP genomes. Cells were subsequently infected with the
standard virus to supply trans-acting factors and structural proteins, resulting in the production of recombinant DIP and the rapid progression to persistent infection. Details are given
in the text and in Materials and methods.
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construct allowed for rDIP quantitation. Supernatant from each
passage was serially diluted and used to infect new monolayers.
Helper (standard) virus was added to each sample at an MOI of 0.1.
Infected monolayers were incubated for 5 days in medium containing
a β-galactosidase substrate. Cells were ﬁxed without staining and blue
plaques were enumerated. rDIP replicated faithfully to high concen-
trations (N1.0×104 per mL) for the ﬁve passages tested (Table 1). In
contrast, cells not transfected or transfected with only the empty
parent vector (pSV-β-galactosidase) did not produce blue plaques at
levels detectable by these methods (Table 1).
rDIP mediate a progression to persistent infection
Two hallmarks of EHV-1 persistently infected cells are: 1)
resistance to lysis by the standard virus; and 2) the ability to release
both standard virus and DIP (Henry et al., 1979, 1980; Robinson et al.,
1980; Dauenhauer et al., 1982). To determinewhether rDIPmediated a
progression to persistent infection, supernatant from cells transfected
with rDIP constructs was collected at each passage (72 h) and used to
infect fresh monolayers. Monolayers were subsequently infected with
standard virus and monitored for the development of lysis resistant
colonies. Cells treated with supernatant from cells transfected with
plasmids containing whole DIP genomes produced lysis resistant
colonies at levels greater than cells treated with empty vector
preparations or cells infected with only wild-type (wt) virus (Fig. 3).
Supernatant from each preparation was used to inoculate fresh
monolayers to conﬁrm the presence of standard virus (Table 2). In
each case, standard virus was isolated from both rDIP and wt DIP
preparations. Thus, rDIP mimic wt DIP in their ability to mediate a
progression to persistent infection as measured by production of cells
that are lysis resistant yet also release both infectious virus and DIP.Table 1
rDIP replication in EHV-1-infected cells
Blue plaque forming units per mL
Pass no. Empty vector DIP1 DIP2 DIP3 Control
1 None 3.4×106 3.2×106 1.2×104 None
2 None 1.2×107 3.2×107 2.0×106 None
3 None 1.3×107 8.9×106 1.7×106 None
4 None 2.6×106 7.7×106 5.7×106 None
5 None 6.0×104 6.0×104 2.4×104 None
rDIP were generated as described in Materials and Methods. Empty vector=cells were
transfectedwith only the parent vector pSV-β-galactosidase; DIP1, DIP2, and DIP3=cells
were transfected with DIP genomes cloned into pSV-β-galactosidase; Control=cells
were not transfected prior to infection.rDIP interfere with standard virus replication
A third hallmark of persistent infection is DIP-mediated reduction
in standard virus replication. The ability of rDIP to interfere with virus
replication was measured by quantifying the concentration of
standard virus in rDIP infected cells at each passage. Supernatant
was collected, serially diluted, and used to infect fresh RK-13
monolayers, and plaques were counted after 24 h. Standard virus
replication was inhibited as early as the third passage in cells
transfected with rDIP constructs. In cells transfected with rDIP1 or
rDIP2, standard virus replication was reduced 1000-fold by the fourth
passage (Fig. 4). In contrast, standard virus replication remained highFig. 3. Persistent infection mediated by wild-type and recombinant EHV-1 DIP.
Monolayers were infected with the standard virus, supernatant from cells transfected
with the empty parent vector (negative control), supernatant of wild-type DIP infected
cells, or supernatant of recombinant DIP (rDIP3 shown here) infected cells. Lysis
resistant colonies were stained for visualization. Cells infected with standard virus or
supernatant from cells transfected with only the empty parent vector and infected with
the standard virus were completely lysed. In contrast, cells infected with supernatant
from rDIP or wt DIP infected cells formed lysis resistant colonies.
Table 2
Release of standard virus by wtDIP- and rDIP-infected cells
Virus/DIP preparation Virus in supernatant (log pfu/mL±SD)
Standard EHV-1 2.9±0.05
Wt DIP 6.1±0.10
Empty vector 2.2±0.04
rDIP1 3.7±0.06
rDIP2 2.7±0.09
rDIP3 5.2±0.02
Persistent infection mediated by rDIP set up as described in the Materials and Methods.
Monolayers of RK-13 cells were infected with the supernatant from cells infected with
the standard virus, wild-type DIP generated from repeated high multiplicity infection
with the standard virus (DI-172; 172nd high multiplicity passage) or recombinant DIP
preparations (rDIP1, rDIP2, rDIP3; see Table 3 for genotypes). Plaques were quantitated
after 24 h. Empty vector = cells transfected with pSV-β-galactosidase containing no DIP
gene sequences (parent vector).
Table 3
Plasmid nomenclature and characteristics
Plasmids Characteristics
pDIP1 Contains genome of EHV-1 defective interfering
particle #1 (see Fig. 1)
pDIP1KO Contains genome of EHV-1 defective interfering
particle #1 deleted of UL3, UL4, and Hyb2.0
pDIP1HybR pDIP1KO with Hyb2.0 restored
pDIP2 Contains genome of EHV-1 defective interfering
particle #2 (see Fig. 1)
pDIP2KO Contains genome of EHV-1 defective interfering
particle #2 deleted of UL3, UL4, Hyb1.0
pDIP2HybR pDIP2KO with Hyb1.0 restored
pDIP3 Contains genome of EHV-1 defective interfering
particle #3 (see Fig. 1)
pGFP vector pIRES-hrGFP-2a (Stratagene, CA)
pGFP-DIP1 pGFP vector with genome of DIP1
pGFP-DIP1KO pGFP vector with genome of DIP1KO
pGFP-DIP1KO-IR4(1–271) pGFP-DIP1KO with IR4(1–271)
pGFP-DIP1KO-IR4(1–196) pGFP-DIP1KO with IR4(1–196)
pGFP-DIP1KO-IR4(1–143) pGFP-DIP1KO with IR4(1–143)
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and in infected cells transfected with only the parent vector (negative
controls).
In the case of rDIP1 and rDIP2 infected cells, standard virus
replication increased to initial levels by the ﬁfth passage. This same
phenomenon (Von Magnus effect; Pauker et al., 1959) is seen in wt
EHV-1 persistent infections where concentrations of standard virus
increase and decrease as the concentrations of DIP reach and fall
below inhibitory levels.
Interference during persistent infection is mediated by HYB proteins
To determine which DIP elements are involved in interference
during persistent infection, rDIP containing deletions in UL3, UL4 and
either Hyb1.0 (DIP2KO) or Hyb2.0 (DIP1KO) were generated (see Table
3 and Fig. 1 for full genotypic descriptions). The Hyb1.0 or 2.0 genewas
restored to the DIP2KO and DIP1KO constructs to generate DIP2HybR
and DIP1HybR, respectively. The absence of Hyb protein expression by
DIP1KO and DIP2KO was conﬁrmed by western blot analyses (Figs. 5C
and 5D, respectively). Likewise the restoration of Hyb protein
expression by DIP1HybR and DIP2HybR was also conﬁrmed by
western blot analysis (Figs. 5C and D, respectively).
When all rDIP were tested for interference activity, cells trans-
fectedwith the rDIP1KO or rDIP2KO constructs that were deleted of all
functional genes showed no interference through passage ﬁve (Figs.
5A and B). In contrast, cells transfected with Hyb1.0 or Hyb2.0
restoration constructs (i.e., constructs containing Hyb1.0 or Hyb2.0 butFig. 4. EHV rDIP interfere with the replication of standard EHV-1. LM cells were
transfected with plasmids containing different EHV-1 rDIP genomes and subsequently
infected with the standard virus (MOI=1.0). Standard virus was quantitated at each
passage (72 h) by plaque assay. Empty vector = cells transfected with pSV-β-
galactosidase; DIP1, DIP2, DIP3 = cells transfected with EHV-1 rDIP genomes cloned
into pSV-β-galactosidase; Control = cells not transfected prior to infection.not UL3 or UL4) displayed interference levels similar to those observed
for cells transfected with the standard rDIP, indicating that the HYB
proteins are capable of mediating interference during persistent
infection. rDIP were also quantiﬁed at each passage as previously
described, and deletion of UL3, UL4, and either Hyb gene had no effect
on rDIP replication as cells transfected with rDIP1KO or rDIP2KO
constructs produced blue plaques at levels similar to those of cells
transfected with other rDIP constructs (Table 4).
Since restoration of either Hyb1.0 or Hyb2.0 restored interference
activity, the IR4 protein sequences (aa 1 to 196) conserved in the Hyb
proteinmay be important for DIP-mediated interference. To address this
possibility, DIP1 and DIP1KO were cloned into the bacterial plasmid
pIRES-hrGFP-2a (Stratagene, CA), and portions of the IR4 gene were
cloned into themultiple cloning site (Fig. 6; seeMaterials andmethods).
The HA tagged IR4 proteins were expressed by the human cytomega-
lovirus (CMV) immediate early (IE) promoter, and expression was
conﬁrmed by western blot analysis (Fig. 6B). The method for rDIP
generation with pGFP-DIP1 plasmids was modiﬁed from that shown in
Fig. 2 in that the cells were washed at 4 h postinfection in the case of
passages 2 to 5. In cells transfected with pGFP-DIP1 and infected with
EHV-1, standard virus replication was reduced 320-fold by the third
passage as compared to that of cells transfectedwith the GFP vector (Fig.
7A). Interestingly, interference with standard virus replication was
achieved by some rDIP that expressed only a portion of the IR4 protein.
Interference was achieved but was delayed to the fourth passage in the
case of GFP-DIP1KO-IR4(1–271) and GFP-DIP1KO-IR4(1–196) (Figs. 7A
and B). However, DIP1KO expressing IR4(1–143) did not interfere with
standard virus replication (Fig. 7B). These results suggested that the IR4
protein residues 144 to 196 are important for DIP interference.Discussion
The progression from lytic infection to persistent infection has been
observed for a variety of different viruses (Huang and Baltimore, 1970;
Campbell et al., 1976; Barrett and Dimmock 1984; Deng et al., 2004;
O'Callaghan and Osterrieder 2006, Ebner and O'Callaghan, 2006). The
biological properties of this altered state of infection, however, remain
understudied and unclear. In the case of EHV-1, persistent infection
arises simultaneously with the production of defective interfering
particles. EHV-1 DIP are unique in that the recombination events that
produce DIP genomes result in the generation of one of two unique
hybrid genes, Hyb1.0 and Hyb2.0, both being fusions of portions of two
well characterized regulatory genes, IR4 and UL5 (Yalamanchili et al.,
1990; Chen et al., 1996, 1999; Fig. 1). To our knowledge, these are the
only unique genes produced by defective particles of an animal virus.
Fig. 5. Interference with standard virus replication during persistent infection can be mediated by HYB proteins. Cells were transfected with rDIP plasmids containing various
deletions described previously. Deletion of UL3, UL4, and either Hyb2.0 (DIP1KO; panel A) or Hyb1.0 (DIP2KO; panel B) resulted in a loss of interference. Restoration of either Hyb gene
alone restored interference (DIP1HybR and DIP2HybR). (C, D) Detection of the IR4 protein encoded by standard virus and detection of the Hyb proteins encoded by rDIP were carried
out by western blot analysis using anti-IR4 protein antiserum.
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defective interfering particles in particular, has been hampered by the
difﬁculty in separating infectious particles from defective particles.
What is more, persistently infected cells release a heterogeneous
mixture of DIP with, in many cases, large genotypic differences (Ebner
and O'Callaghan, 2006). Here, these problems were circumvented by
employing a system whereby persistent infection was mediated by
recombinant DIP (Figs. 1 and 2). Transfecting cells with plasmids
containing DIP genomes and subsequently infecting with standard
virus rapidly produced persistently infected cells that released
recombinant DIP. Inclusion of a functional LacZ gene allowed the
quantiﬁcation of DIP based on the ability to produce blue plaques. In
this system rDIP replicated to at least ﬁve passages at which time the
experiments were terminated. Moreover, like wt DIP, rDIP mediated a
progression to persistent infection as measured by: 1) lysis resistance;
2) release of both standard virus and DIP; and 3) inhibition of standard
virus replication.
rDIP constructs deleted of UL3, UL4, and either Hyb gene exhibited
a great reduction in the ability to interfere with standard virusTable 4
Deletion of UL3, UL4, and either Hyb gene does not affect rDIP replication
Blue plaque forming units/mL
Passage Empty DIP1 DIP1KO DIP1Hyb DIP2 DIP2KO DIP2HYB
1 b100 1.2×106 1.0×106 1.7×106 8.4×105 5.8×105 3.8×106
2 b50 5.0×106 4.9×106 8.9×106 4.5×106 6.1×106 7.2×106
3 b50 2.6×106 6.0×106 1.6×105 5.9×106 6.8×106 4.0×106
4 b50 1.1×106 3.5×105 1.0×105 6.0×105 2.7×106 2.0×106
5 b50 6.0×105 1.8×105 7.7×104 8.8×104 3.0×105 2.1×106
Recombinant DIP were generated as described in Materials and Methods. DIP
quantitation was based on lacZ production and generation of blue plaques. DIP1KO =
DIP1 deleted of UL3, UL4, and Hyb2.0; DIP1HybR = DIP1KO with Hyb2.0 restored;
DIP2KO = DIP2 deleted of UL3, UL4, and Hyb1.0; DIP2HybR = DIP2KO with Hyb1.0
restored.replication. Restoring either Hyb1.0 or Hyb2.0 alone restored inter-
ference. Our data support a model whereby the standard virus
genome undergoes recombination events that generate IR4/UL5
hybrid genes that encode HYB proteins capable of reducing standard
virus replication to sub-lethal levels, resulting in lysis resistant cells
that release both infectious virus and a heterogeneous mixture of DIP.
It follows that UL3 and UL4 do not appear necessary for interference,
albeit their role in generating DIP genomes remains to be tested in
future experiments.
While each Hyb gene contains 5′ portions of IR4 and 3′ portions of
UL5, the majority of amino acid sequences in each of the HYB proteins
comes from the IR4 protein; Hyb1.0 and Hyb2.0 contain 67% and 78%
of the parent IR4 protein, respectively. What is more, the UL5
sequences retained in Hyb2.0 are not in-frame which results in an
early termination and the addition of 15 amino acids not found in
either parent protein. While each HYB protein retains several
functional domains of the parent IR4 protein, namely domains that
mediate self-dimerization and interactions with the IE protein (IEP)
and cellular TATA box-binding protein, neither HYB protein retains an
NLS (Holden et al., 1994, 1995; Derbigny et al., 2000, 2002; Ebner and
O'Callaghan, 2006; Ebner and O'Callaghan unpublished results 2008).
Indeed, previous studies showed that in contrast to both IR4P and
UL5P, each HYB protein displays a diffuse cytoplasmic staining pattern.
As such, it was originally hypothesized that the HYB proteins might
mediate interference by acting as a sink for important regulatory
proteins, preventing their nuclear entry. Our preliminary studies
indicated, however, that the viral IE, UL5, and IR4 proteins as well as
cellular TBP were able to localize to nuclei of cells also producing
either the HYB1.0 or HYB2.0 protein (Ebner and O'Callaghan, 2006).
Those studies, however, employed transiently transfected cells which
may not be ideal for studying the properties of DIP-associated proteins
as the amount of HYB protein produced during persistent infection
may dwarf that produced in cells simply transfected with plasmids
containing Hyb genes. As such, further experiments are planned to
Fig. 6. Generation of DIP1KO plasmids expressing truncated IR4 proteins. (A) Structures of pGFP-DIP1 plasmids expressing the truncated forms of IR4P. Truncated IR4 genes were
inserted into the multiple cloning site (MCS) of pIRES-hrGFP-2a (Stratagene, CA). hrGFP, humanized recombinant green ﬂuorescent protein. (B) Western blot analysis of IR4P
truncation mutants. NBL6 cells were nucleofected with 1 pmol of pGFP-DIP1KO-IR4(1–271), pGFP-DIP1KO-IR4(1–196), pGFP-DIP1KO-IR4(1–143), or pGFP-DIP1KO. Cytoplasmic (C)
and nuclear (N) extracts were prepared and subjected to SDS-PAGE, and the proteins were blotted to nitrocellulose and stained with the monoclonal anti-HA antibody (12CA5; Santa
Cruz Biotechnology, Inc., CA). The arrow indicates the IR4(1–143). The numbers on the left represent molecular mass standards (Bio-Rad, CA) in kilodaltons.
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unique anti-viral properties of these proteins is achieved.
Our ﬁndings (Fig. 7) suggested that the IR4P residues 144 to 196
that harbor domains for TBP-binding (aa 142–220) and IEP binding (aa
142–239) are important for DIP interference (Derbigny et al., 2000,
2002; Ebner and O'Callaghan, unpublished data). In related experi-
ments, we have shown that the unique EHV-1 IR2 protein (IR2P)
negatively regulates viral gene expression and production, and
interacts with TFIIB and TBP (Kim et al., 2006). Our observations that
both the IEP and IR2P interact with TFIIB and TBP led to the hypothesis
that the IR2P down-regulates EHV-1 gene expression by binding to
viral promoters to prevent IEP binding and/or by squelching cellular
factors essential for viral gene expression. The HYB1.0 and 2.0 proteins
contain IR4P aa 1–196 and aa 1–228, respectively. Our published data
showed that the IR4P minimally trans-activates EHV-1 promoters and
acts synergistically with IEP and UL5P to trans-activate early and late
viral promoters (Holden et al., 1995; Derbigny et al., 2002; Kim et al.,
1997). Two C-terminal mutants of the IR4P IR4(1–271) and IR4(1–196)
still trans-activated the EHV-1 EICP0 promoter; however, IR4(1–143)
failed to trans-activate the early EICP0 promoter (data not shown),
indicating that the IR4P residues 144 to 196 harbor sequences that are
essential to mediate EHV-1 gene activation. These results suggest that
during persistent infection, the HYB proteins, which are produced in
enormousquantities, could interferewith standard virus replicationby
squelching cellular and viral factors essential for viral gene expression.
It follows that truncation of IR4P residues 144 to 196 may alter the
conformation of the protein such that the active inhibition site is not
functional due to gross changes in structure. It should be noted,
however, that interference could also result from cis-acting elements
or trans-acting RNAs associated with Hyb1.0 or Hyb2.0. While we do
not have any evidence of this, future experiments will need to be
conducted to completely rule out this scenario.
It is unclear as to the mechanism(s) behind lysis resistance. It is
possible that the HYB proteins may be involved in this process as well
but this question was outside the scope of the current manuscript. It
follows that the UL3 and UL4 proteins, while appearing to be
unnecessary for interference, could play roles in the establishment of
lysis resistance as well. As such, our laboratory is currently character-
izing the functions of UL3 and UL4 (both during lytic and persistentinfection), and themethod described here of using recombinant DIP to
study persistent infection should be able to address these and other
questions regarding this altered state of infection.
Materials and methods
Virus and cells
EHV-1 Kentucky A (KyA) strain was propagated in mouse LM
ﬁbroblasts (O'Callaghan et al.,1968). LM cells were used in transfection
assays. Rabbit kidney (RK-13) cells were also used for both infectious
virus and rDIP quantitation.
Plasmids and DNA sequencing
Plasmid nomenclature and characteristics are described in Table 3.
The insertion of three DIP genomes (DIP1, DIP2, and DIP3) into bacterial
plasmids is described elsewhere (Baumann et al., 1986). XbaI fragments
containing entire DIP genomes of each plasmid were inserted into the
XbaI site of the plasmid vector pSV-β-galactosidase (Invitrogen,
Carlsbad, CA), resulting in the rDIP plasmids pDIP1, pDIP2, and pDIP3.
pDIP1KO and pDIP2KO were generated by digesting pDIP1 and pDIP2
with BamHI and XbaI which released fragments containing the DIP
genomes deleted for UL3, UL4 and Hyb2.0. The truncated DIP genomes
were then religated into theparent plasmid. pDIP1HybRandpDIP2HybR
were generated by digesting pDIP1 and pDIP2 with SalI and BglII which
removed UL3 and UL4. The ends were ﬁlled in with Klenow fragment,
and the backbones were religated. Sequence arrangements were
conﬁrmed by DNA sequence and restriction enzyme analyses. Fig. 1
describes the organization of the rDIP plasmids. To generate pGFP-DIP1,
the XbaI fragment (DIP1 portion) of pDIP1 was cloned into the XbaI site
of pIRES-GFP-X which was generated by inserting an XbaI linker (5′-
CTAGTCTAGACTAG-3′) into NsiI site of pIRES-hrGFP-2a (Stratagene, CA).
The XbaI fragment of pDIP1KO was cloned into the XbaI site of pIRES-
GFP-X to generate pGFP-DIP1KO. The EcoRI and NheI fragment of pcDR4
(Holden et al., 1994) was cloned into the EcoRI and NheI sites of
pSVSPORT1 (GIBCO BRL) to generate pSPORT-IR4(1–271). Plasmid
pSPORT-IR4(1–271) was digested with NheI, and ﬁlled with Klenow
fragment, and a SalI linker (5′-CGGTCGACGG-3′) was inserted and the
Fig. 7. Interference with standard virus replication during persistent infection can be mediated by IR4P aa 144 to 196. (A and B) DIP interference assays with pGFP-DIP1KO plasmids
expressing IR4 mutants. LM cells were transfected with plasmids containing different EHV-1 DIP genomes and subsequently infected with the standard virus (MOI=1.0). Standard
virus was quantitated at each passage (72 h) by plaque assay. The data are representative of four independent experiments. (C) Schematic diagram of HYB proteins and the deletion
mutants of the IR4P. The top diagram represents the 293-aa IR4P of EHV-1. The numbers refer to the number of amino acids from the N-terminus of each protein. TBP, TATA box-
binding protein; NLS, nuclear localization signal.
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fragment was cloned into the EcoRI and SalI sites of pGFP-DIP1KO to
generate pGFP-DIPKO-IR4(1–271). To generate pGFP-DIP1KO-IR4(1–
143), the EcoRI and XhoI fragment of pcDR4 was cloned into the EcoRI
and SalI sites of pGFP-DIP1KO. The 0.6-kb N-terminal DNA fragment of
the IR4 gene from pcDR4 was ampliﬁed by PCR with the primers IR4-
196-F (5′-AGAAGGTACGCCTGCAGGTACCGGTCCGGA-3′) and IR4-196-R2
(5′-GGGGTCGACGGCCGCTCACGTCACACTCCTCCCCAAA-3′) and cloned
into the EcoRI and SalI sites of pGFP-DIP1KO to generate pGFP-
DIP1KO-IR4(1–196).
rDIP generation and quantitation (blue plaque assay)
LM cells were transfectedwith the different rDIP constructs using a
previously described lipofectin technique (Chen et al., 1999). Brieﬂy,
cells (5×105) were seeded at 80% conﬂuence, allowed to attach,
washed three times, and then incubated for 5 h with 1–10 μg of DNA
resuspended in 20% lipofectin (Invitrogen). The lipofectin/DNA solu-
tion was replaced with Eagle's standard medium containing 5% fetal
calf serum, and the cellswere incubated for 24h. Transfected cellswere
subsequently infected with the standard virus (MOI=1.0) and
incubated at 37 °C. Infected cells were harvested at 72 h and diluted1:5 in medium containing 2×106 cells/mL. Cells were passaged
similarly four more times every 72 h. rDIP were quantitated by infect-
ing RK-13 monolayers with serial dilutions of each passage sample.
Each sample was then infected with helper virus (wild-type EHV-1) at
MOI=1. Infected monolayers were incubated in medium containing
Bluo-gal (Difco, Livonia, MI) for 5 days. Cells were ﬁxed with formalin
and blue plaqueswere visualized and quantitated over a light box. rDIP
concentrations were expressed as blue plaque forming units/mL. The
generation of recombinant DIP is described schematically in Fig. 2.
Virus quantitation
Serial dilutions of samples from each passage were used to
inoculate fresh RK-13 monolayers. Infected monolayers were incu-
bated in medium containing 1.5% methylcellulose. Plaques were
quantitated after 3 days by ﬁxing with 10% formalin and staining
with 0.5% crystal violet.
rDIP mediated persistent infection
RK-13 cell monolayers were infected with the equivalent of 0.1 DI
particle/cell for all preparations containing rDIP, and 2 mL of DI72
105P.D. Ebner et al. / Virology 381 (2008) 98–105(wild-type DIP; 1.1×107 PFU/mL). Infectious EHV-1 was added if
necessary so that each infection was standardized to MOI of 20
(infectious virus). At 6 h post infection, infected cells were trypsinized
and reseeded at 1:4 dilution. Lysis resistant colonies were ﬁxed at 2–
3 weeks and stained with 0.5% crystal violet for visualization and
quantitation. The number of cells in lysis resistant colonies was
determined by treating colonies with trypsin, staining live cells with
erythrocin, and counting cells using amicroscope. The concentration of
infectious virus in the supernatant of rDIP preparations was deter-
mined by standard plaque assay as previously described.
Interference and rDIP quantitation
Interference was measured by quantitating the concentration of
standard virus at each passage by standard plaque assay as described
previously.
Western blotting
Extracts from cells infected with rDIP and standard virus were
collected at the third passage. Proteins were isolated in RIPA buffer,
separated by SDS-PAGE, and electrophoretically transferred to a
positively charged nylon membrane (Bio-Rad, Hercules, CA). Mem-
branes were blocked in 1% skim milk, rinsed in TBST, and incubated
with the primary antibody (α-IR4 polyclonal antiserum; 1:10,000;
Holden et al., 1994). Membranes were then washed again and
incubated with a 1:10,000 dilution of secondary antibody (alkaline
phosphatase-conjugated goat α-rabbit antiserum; Sigma, St Louis,
MO). Protein–antibody complexes were visualized by incubating the
membranes in NBT/BCIP solution (Sigma) according to the instruc-
tions from the manufacturer.
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